<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02834377</url>
  </required_header>
  <id_info>
    <org_study_id>TAPIR-1.0</org_study_id>
    <nct_id>NCT02834377</nct_id>
  </id_info>
  <brief_title>Personalized Hemodynamic Therapy in Patients Undergoing High-risk Surgery</brief_title>
  <acronym>TAPIR</acronym>
  <official_title>Individualized Goal-directed Hemodynamic Therapy Targeting Preoperatively Assessed Personal Cardiac Output Values in Patients Undergoing High-risk Surgical Procedures: a Prospective and Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of using the personal
      preoperatively assessed cardiac output in high-risk patients to guide perioperative
      administration of fluids and vasoactive drugs on predefined postoperative complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 19, 2016</start_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of study participants with at least one complication of a composite of 30-day postinterventional complications</measure>
    <time_frame>up tp 90 days after study enrollment</time_frame>
    <description>composite of 30-day postinterventional complications defined according to the ESA-ESICM guidelines for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine (acute kidney injury stage 1 or higher [KIDGO]; ARDS; anastomotic breakdown [moderate and severe]; arrhythmia [severe]; cardiac arrest; cardiogenic pulmonary oedema [severe]; deep vein thrombosis [moderate and severe]; delirium; GI bleeding [severe]; Infection, source uncertain [severe]; bloodstream infection [severe]; myocardial infarction [severe]; pneumonia [severe]; paralytic ileus [severe]; postoperative haemorrhage [severe]; pulmonary embolism [severe]; stroke [severe]; superficial, deep, organ/space surgical site infection [severe]; urinary tract infection [severe]; death)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>7-day-mortality</measure>
    <time_frame>up to 7 days after study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day-mortality</measure>
    <time_frame>up to 30 days after study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90-day-mortality</measure>
    <time_frame>up to 90 days after study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>up to 90 days after study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital length of stay</measure>
    <time_frame>up to 90 days after study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative morbidity survey on days 3, 7, 14, 30</measure>
    <time_frame>up to 90 days after study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative cognitive dysfunction</measure>
    <time_frame>up to 90 days after study enrollment</time_frame>
    <description>from day 3 after surgical intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of the vascular function as prognostic parameters for immunological complications (syndecan 1, sphingosine 1-phosphate, asymmetric dimethylarginine [ADMA], symmetric dimethylarginine [SDMA], arginine, homoarginine</measure>
    <time_frame>up to 90 days after study enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">188</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Treatment algorithm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients allocated to the study group will be connected to a cardiac output monitor. An initial haemodynamic assessment will be performed at the beginning of surgery and at regular time intervals (every 15 minutes) during surgery. The personal cardiac output value is targeted.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients allocated to the control group will receive the standard care of the hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment algorithm targeting individual cardiac output</intervention_name>
    <arm_group_label>Treatment algorithm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients ≥ 18 years undergoing a major abdominal procedure (including general,
             urological, gynaecological, and vascular) with an expected duration of surgery ≥ 90
             min or presumed blood loss exceeding 1,000 mL (e.g., intrabdominal vascular surgery)
             and ≥ 1 of the following high-risk criteria:

          -  acute or chronic renal impairment (serum creatinine ≥ 1.3 mg/dL)

          -  predefined risk factors for cardiac or respiratory complications

          -  Immunodeficiency due to a therapy (e.g., immunosuppressants, chemotherapy, radiation,
             long-term or high-dose steroids)

          -  Immunodeficiency due to specific diseases (e.g., leukaemia, lymphoma, AIDS)

          -  severe liver impairment (biopsy proven liver cirrhosis plus 1 of the following: portal
             hypertension or history of upper gastrointestinal bleeding due to portal hypertension
             or previous episodes of hepatic insufficiency/hepatic encephalopathy/hepatic coma

          -  Age ≥ 80 years

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Pregnancy

          -  surgery for palliative treatment

          -  emergency procedure

          -  refusal of consent

          -  participation in another randomized controlled trial

          -  failure to meet inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernd Saugel, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julia Wagner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Anästhesiologie, Zentrum für Anästhesiologie und Intensivmedizin, Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2016</study_first_submitted>
  <study_first_submitted_qc>July 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2016</study_first_posted>
  <last_update_submitted>August 3, 2017</last_update_submitted>
  <last_update_submitted_qc>August 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac Output</keyword>
  <keyword>Hemodynamics</keyword>
  <keyword>Perioperative Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

